awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37969893-A00FBDAD-41F3-49E9-AF12-D91BEA20B56C
Q37969893-A00FBDAD-41F3-49E9-AF12-D91BEA20B56C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37969893-A00FBDAD-41F3-49E9-AF12-D91BEA20B56C
Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.
P2860
Q37969893-A00FBDAD-41F3-49E9-AF12-D91BEA20B56C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37969893-A00FBDAD-41F3-49E9-AF12-D91BEA20B56C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c38935da7e71ad821d3b3a93d891d25bca373b97
P2860
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome